| |
PROF.DR.NURDAN TÖZÜN’ÜN BİLİMSEL ÇALIŞMALARI
BİLİMSEL YAYINLARI
1. Uluslararası hakemli dergilerdeki yayınlar:
1,The effect of chronic guanfacİne administration on high plasma vasopressin levels in essential hypertension.
Berkman, K., Tözün, N., Taga, Y., Dedeoğlu, A., Onat, F., Bekiroğlu, N.
Int J Pharmacol Ther Toxıcol 28: 67-71,1990.
2.Effect of diltiazem on renal functions in patients with liver cirrhosıs.
Tözün, N., Berkman, K., Tankurt, E., Kalaycı, C., Özdoğan, O., Aran, S.,Taga,Y.
Int J Clin Pharmacol Ther Toxıcol 29: 208-213, 1991.
3.Safety of alcohol after viral hepatitis.
Tözün, N., Forbes, A., Anderson, M.G., Murray-Lyon, I.M.
Lancet 337: 1079-1080, 1991.
4.Cerebral echinococcosis multilocularis: Case report.
Pamir, MN., Özer AF., Keleş GE., Tözün N., Gürmen N., Küllü S.
J.Neurosurg Sci 35: 161-164, 1991.
5..Endoscopic removal of swallowed endotracheal tubes from two patients. An
unusual complication of coronary by-pass surgery.
Kalaycı C., Tözün n., Ulusoy N.B.
Endoscopy 26: 364, 1994.
6. The effect of endothelin-1 on vena jugularis thrombus model in rabbits
Ulutin T,Bayram C,Okar I,Ozluk K,Tözün N,Ulutin ON
J Basic Clin Physiol Pharmacol 1995;6:296-302
7.Refractory duodenal ulcer healing and relapse: Comparison of omeprazole versus
helicobacter pylori eradication.
Avşar E., Kalaycı C., Tözün N., Gültekin O., Kızıltaş Ş., Ulusoy N.B.
Eur J Gastroenterol 1996 8: 449-452.
8.Clostridium Difficile acquisition rate and its role in nosocomial diarrhea at a
University Hospital in Turkey.
Söyletir G., Eskitürk A., Kılıç G., Korten V., Tözün N.
Eur J Epidemiol 12: 391-394, 1996.
9.Toothpick impaction: treatment by colonoscopy
Över H., Tözün N., Avşar E.
Endoscopy 29: 560-561, 1997.
10.Long term efficacy of Interferon alpha and Ursodeoxycholic Acid in the treatment
of chronic type C hepatitis.
Şentürk H., Uzunalimoğlu Ö., Batur Y., Şimşek I and Tözün N.
Dig Dis Sci 42: 1438-1444, 1997.
11.Successful treatment of polyarteritis nodosa related to hepatitis B virus
with interferon alpha as first line therapy.
Avşar E., Savaş B., Tözün N., Ulusoy N., Kalaycı C.
J Hepatol 28: 525-26, 1998.
12. Thrombophylia and Inflammatory Bowel Disease:does Factor V Leiden
mutation have a role ?
Över Hamzaoğlu H Ülgen S.,., Tuğlular T., Avşar E., Kalaycı C., Tözün N.
Eur J Gastroenterol Hepatol 1998 ;10: 827-9.
13.The distribution of HLA-DRB alleles in ulcerative colitis patients in Turkey
Uyar FA,Imeryüz N, Dreskeneli Çeken H,Özdoğan O,Tözün N
J Immunogenetics 1998; 25:293-296
14.Influence of the metabolic complications of liver cirrhosis on dietary intake
Tözün N
Med Sci Monit 2000; 6:46-50
15.Risk factors for hepatocellular carcinoma in Turkey
Uzunalimoğlu Ö,Yurdaydın C,Çetinkaya H,Bozkaya H,Şahin T,Çolakoğlu S,
Tankurt E, Sarıoğlu M,Özenirler S,Akkız H,Tözün N, Değertekin H,Ökten A
Dig Dis Sci 2001,46:1022-1028
16.Role of Endothelin in a cirrhotic rat model with endotoxin induced acute renal failure.
Özdoğan O,Gören Z,Ratip S,Giral A ,Bilsel S,. Moini H,Enç ,FBerkman K and Tözün N
Hepatology Research,2002, 24:114-124
17.Clinical and epidemiological data on Inflammatory bowel disease, colorectal
cancer and helicobacter pylori infection in Turkey (Invited Review)
Tözün N
Ann of Gastroenterol 2002,15:364-371
18. Epidemiology of Viral hepatitis in the Mediterranean basin
Tözün N
Iatriki 2002,6:21-31
19.Causes and risk factors for liver injury following bone marrow transplantation
Özdoğan O,Ratip S,Al -Ahdab Y, Dane F,Al-Ahdab H,İmeryüz N,Tözün N
J Clin Gastroenterol ,2003: 36:421-26
20.Clinical outcome of Crohn’s disease treated with Infliximab
Arslan S,Kav T,Beşışık F,Kaymakoğlu S,Pınarbaşı B,Tözün N, Hamzaoglu H,
Duman D,Ülker A,Parlak E,Palabıyıkoğlu M,Dökmeci A
Hepatogastroenterology 2003,50:952-956
21. Antral hyperplastic polyp causing intermittent gastric outlet obstruction: Case report.
Gencosmanoglu R, Sen-Oran E, Kurtkaya-Yapicier O, Tozun N.
BMC Gastroenterol. 2003 Jun 27;3(1):16.
22. Percutaneous endoscopic gastrostomy: results of 115 cases.
Gencosmanoglu R, Koc D, Tozun N.
Hepatogastroenterology. 2003 May-Jun;50(51):886-8.
23. Effects of selective COX-2 inhibitors on the gastric permeability of sucrose: a
controlled study with placebo and ibuprofen.
Ekenel M, Avsar E, Imeryuz N, Yuksel M, Haklar G, Kocakaya O, Tozun N.
Eur J Gastroenterol Hepatol. 2003 Apr;15(4):403-6.
24. Gastric polypoid lesions: Analysis of 150 endoscopic polypectomy specimens
from 91 patients
Gencosmanoglu R, Sen-Oran E, Kurtkaya-Yapicier O, Avsar E, Sav A,Tozun N.
World J Gastroenterol 2003 ;9:2236-2239
25.Adrenomedullin in cirrhotic and non cirrhotic portal hypertension
Tahan V,Avsar E,Karaca Ç,Uslu E,eren F,Aydın S, Uzun H,
Hamzaoglu HO,Beşışık F,Kalaycı C,Ökten A, Tözün N
World J Gastroenterol 2003 ;9:2325-2327
26. Epidemiology of viral hepatitis in the Mediterranean basin.
Tahan V,Ozdogan O,Tözün N
Rocz Akad Med Bialymst. 2003;48:11-7. Review.
27.The Buried Bumper Syndrome:Migration of the internal bumper of percutaneous
endoscopic gastrostomy tube into the abdominal wall;case report.
Gencosmanoglu R, Koc D, Tozun N.
J Gastroenterol. 2003;38(11):1077-80.
28..Xantelasmas of the upper GI tract
Gencosmanoglu R, Sen-Oran E, Kurtkaya-Yapicier O, Tozun N.
J Gastroenterol
29. Bouveret’s syndrome complicated by a distal gallstone ileus: case report
Gençosmanoğlu R, İnceoğlu R, Baysal Ç, Akansel S, Tözün N
World J Gastroenterol 2003 Dec;9(12):2873-5.
30. The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction
of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?
Kurtkaya-Yapicier O, Gencosmanoglu R, Avsar E, Bakirci N, Tozun N, Sav A.
BMC Clin Pathol. 2003 Dec 2;3(1):5.
31. Anti-HCV Seroprevalence in Chronic HCV Patients' Children in Turkey.
J Clin Gastroenterol. 2004 Jan;38(1):90-1
32. Prothrombotic gene mutations and Crohn’s disease ;Is there any association ?
Over H,Abacı N,Türe F,Alkın C,Tezel A,Tözün
Hepatogastroenterology. 2005 Sep-Oct;52(65):1467-9.
33. Oral glucose tolerance deteriorates in rats fed with methionine choline deficient diet.
Tahan V, Yavuz D, Imeryuz N, Avsar E, Tozun N.
J Hepatol. 2004 Aug;41(2):352;
34. Mid-esophageal ulceration and candidiasis-associated distal esophagitis as two
distinct clinical patterns of tetracycline or doxycycline-induced esophageal injury.
Gencosmanoglu R, Kurtkaya-Yapicier O, Tiftikci A, Avsar E, Tozun N, Oran ES.
J Clin Gastroenterol. 2004 Jul;38(6):484-9.
35. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced
gastroduodenal mucosal injury.
Giral A, Ozdogan O, Celikel CA, Tozun N, Ulusoy NB, Kalayci C.
J Gastroenterol Hepatol. 2004 Jul;19(7):773-7.
36. The prevalence of hepatic granulomas in chronic hepatitis C.
Ozaras R, Tahan V, Mert A, Uraz S, Kanat M, Tabak F, Avsar E,
Ozbay G, Celikel CA, Tozun N, Senturk H.
J Clin Gastroenterol. 2004 May-Jun;38(5):449-52.
37. Xanthelasmas of the upper gastrointestinal tract.
Gencosmanoglu R, Sen-Oran E, Kurtkaya-Yapicier O, Tozun N
J Gastroenterol. 2004;39(3):215-9.
38. Botulinum toxin injection versus lateral internal sphincterotomy in the treatment
of chronic anal fissure: a non-randomized controlled trial.
Giral A, Memisoglu K, Gultekin Y, Imeryuz N, Kalayci C, Ulusoy NB, Tozun N.
BMC Gastroenterol. 2004 Mar 22;4(1):7.
39. The efficacy, safety and tolerability of pantoprazole-based one-week triple
therapy in H. pylori eradication and duodenal ulcer healing.
Sivri B, Simsek I, Hulagu S, Kadayifci A, Tozun N, Akarsu M,
Uraz S, Savas MC, Koruk M, Bozbas A.
Curr Med Res Opin. 2004 Aug;20(8):1301-7.
40. Hepatology issues in Asia:Perspectives from regional leaders
Khan M,Dong JJ,AcharyaSK,Dhagwadorj Y,Abbas Z,Jafri W SM,
Mulyono DH,Tozun N, Sarin SK
J Gastroenterol Hepatol 2004 ;19: S419-S430
41. Sexual transmission of HCV between spouses.
Tahan V, Karaca C, Yildirim B, Bozbas A, Ozaras R, Demir K, Avsar E, Mert A,
Besisik F, Kaymakoglo S, Senturk H, Cakaloglu Y, Kalayci C, Okten A, Tozun N.
Am J Gastroenterol. 2005 Apr;100(4):821-4.
42. Octreotide in liver cirrhosis: a salvage for variceal bleeding can be a gunshot for kidneys
Guney Duman D, Tuney D, Bilsel S, Benli F, Karan S, Avsar E, Ozdogan O, Tozun
Liver Int. 2005 Jun;25(3):527-38.
43. Prothrombotic gene mutations and Crohn’s disease ;Is there any association ?
Over H,Abacı N,Ture F,Alkın C,Tezel A, Tozun N
Hepatogastroenterology October 2005,52:1467-1469
44. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole
in gastroesophageal reflux disease patients.
Giral A, Celikel CA, Ozdogan O, Tozun N, Ulusoy NB, Kalayci C.
J Gastroenterol Hepatol. 2005 Dec;20(12):1886-91
45. Computed tomography in nonalcoholic fatty liver disease: a useful tool for
hepatosteatosis assessment?
Duman DG, Celikel C, Tüney D, Imeryüz N, Avsar E, Tözün N.
Dig Dis Sci. 2006 Feb;51(2):346-51.
46. Distribution of Common CARD15 Variants in Patients with Sporadic
Crohn's Disease: Cases from Turkey.
Uyar FA, Over-Hamzaoglu H, Ture F, Gul A, Tozun N, Saruhan-Direskeneli
G.Dig Dis Sci. 2006 Apr;51(4):706-10.
47. Epidemiology and Risk Factors in Hepatocellular Carcinoma.
Tozün N. Ann. Gastroenterology. 2005 Apr-June:18 (2): 212-214.
48. Colloid scintigraphy in non-alcoholic steatohepatitis: a conventional
diagnostic method for an emerging disease.
Duman DG, Dede F, Akin H, Sen F, Turoglu HT, Celikel C, Tozun N.
Nucl Med Commun. 2006 Apr;27(4):387-93.
49. Determination of hepatitis B genotypes in patients with chronic
hepatitis B virus infection in Turkey.
Ozdemir FT, Duman D, Ertem D, Avsar E, Eren F, Ozdogan O, Kalayci C,
Aslan N, Bozdayi AM, Tozun N.Turk J Gastroenterol. 2005 Dec;16(4):183-187.
Special article
50 . Women in Gastroenterology, Turkey
World Gastroenterology News vol 8:33-35, 2003
2.. Uluslararası Konferanslarda sunulan sözlü bildiriler
1.Diagnostic value of peritoneoscopy in exudative ascites.
Ökten, A., Tözün, N., Yıldır, C., Yalçın, S., Ulagay, I.
The world Congress of Gastroenterology, 7th Congress, June 14-19, 1982,
Stockholm, Sweden Abstract No: 11.
2.Enzymatic and ultrastructural alterations of jejunal mucosa in relation to giardiasis.
Erol, N., Erbengi, T., Sezr, R., Canberk, Y., Yeğinsu, O., Yıldır, C., Tözün, N.
The World Congress of Gastroenterology, 7th Congress, June 14-19, 1982,
Stockholm, Sweden Abstract No: 652.
3.Congenital cystic disease of the liver.
Tözün, N., Ökten, A., Yeğinsu, O., Yıldır, C., Özdil, S., Gürakar, M.
IV.Seminar über Leberkrankheiten, I.Seminar über Ultraschalldiagnostik in der
Gastroenterologie, İstanbul, Juni 18-19, 1982, Abstract p.33-34.
4.The importance of high protein and calorie intake in cases of Crohn’s disease
with growth retardation.
Erol, N., Sezer, R., Tözün, N., Yeğinsu, O.
IV.Asian Congress on Nutrition, November 1-4, 1983, Bangkok,
Thailand, Abstract Book, p. 212.
5.Splenic vein thrombosis.
Ökten, A., Emre, A., Yalçın, S., Arıoğul, O., Yeğinsu,O., Tözün, N., Ulagay, I.
Hepato-Pancreatico-Biliary Surgery, First World Congress, Lund, Sweden,
June 9-13 1986, Abstract No: 211.
6.Relation between plasma protein C activity and thrombus formation in cases of
presinusodial portal hypertension.
Tözün, N., Ökten, A., Yardımcı, T.
VII. International Congress of Liver Diseases, Basel Liver Week, October 16- 18 1986,
Poster Abstracts, No: 280.
7.The effect of guanfacine on high plasma vasopressin levels in patients with essential hypertension.
Berkman, K., Tözün, N., Taga, Y., Oral, U.
Euro J Clin Pharma 36: A209, 1989.
Europ. Congress of Pharmacology, Mannheim Heidelberg July 23-28, 1989.
8.The effect of captopril on plasma vasopressin levels in essential hypertension.
Berkman, K., Tözün, N., Taga, Y., Oral, U.
XIe Session des Journées Médicales Balkaniques, 25-27 Mai 1989, İstanbul,
Résumés p.117.
9.The central/portal blood ratio of carcinoembryogenic antigen levels in patients with colorectal cancer.
Yalın, R., Yeğen, C., Aktan, Ö., Güllüoğlu, BM, Tözün, N.
XVth Biennial Congress of International Society of University colon and rectal
surgeons, 2-6 July 1994, Singapore, Abstract Book. s.266.
10.The effect of endothelin-1 on vena jugularis thrombus model in rabbits.
Bayram, Ç., Ulutin, T., Okar, I., Özlük, Tözün, N., Ulutin, ON.
First International Meeting on Pharmacy and Pharmaceutical Sciences, 4-7 Sept 1994,
İstanbul ,Abstract Book. s.247.
11.Epidemiology of inflammatory bowel diseases in Turkey
N.Tözün
Workshop of Mediterranean Medical Society IBD group 27 April 1998 İstanbul.
12. Amebic colitis versus ulcerative colitis
7th United European Digestive Disease Week ,Roma November 12-15 1999
Gut 1999;45 S:74 (Lecture notes )
13. Epidemiology of HCV in the Eastern Mediterranean Region
Tözün N
Innovations in the management of HCV infection
Monte Carlo, 3rd-5th February 2003
Abstract Book p 15
15.Pregnancy and the liver
Tözün N ,Akın H
15th ASİAN Pasific Association for the Study of the Liver,,August 18-21,2005
Liver İnternational 1821/VIII, p 64-66
3. Uluslararası konferanslarda sunulan poster tebliğler
1.Endoscopic findings in symptomatic patients after operation for peptic ulcer.
Sezer, R., Erol, N., Yeğinsu, O., Yıldır, C., Özdil, S., Tözün, N.
The World Congress of Gastroenterology, 7th Congress, June 14-19, 1982,
Stockholm,Sweden Abstract No:340.
2.Synchronous and metachronous polyps in patients with colorectal carcinoma.
Tözün, N., Ulusoy, N. B., Kalaycı, C.
Holland Digestive Disease Week, Amsterdam, 21-24 June 1989, Abstract No:119
3.Refractory duodenal ulcer healing and relapse: Comparison of omeprazole versus
helicobacter pylori eradication.
Avşar, E., Kalaycı, C., Tözün, N., Gültekin, O., Kızıltaş, Ş., Ulusoy N. B.
Digestive Disease Week, May 9-12, Boston, 1994 Gastroenterology 1994;106: A42
4.Does eradication of H.Pylori reduce low dose aspirin induced gastrodoudenal
injury ?
Giral, A., Özdoğan, O., Çelikel, Ç., Ulusoy NB, Tözün, N., Kalaycı, C.
Gastroenterology 1997;117:127.
5.Endothelin-1 in hepatorenal syndrome: Is Endothelin antagonist (Bosenthan) effective ?
Özdoğan, O., Tözün, N., Gören, Z., Moini, H., Kızıltaş, Ş., Çelikle, Ç., Berkman, K.
EASL Congress 9-12 April 1997, London
J Hepatol 26 (suppl): 100, 1997.
6.Factor V Leiden mutation in inflammatory bowel disease.
Ülgen, SK., Hamzaoğlu, H., Tuğlular, T., Avşar, E., Kalaycı, C., Tözün, N.
V International symposium on inflammatory bowel diseases Falk symposium No:101,
Jerusalem, September 22-24, 1997, Abstracts. No:53.
7.Relation of HGV to Non-Hodgkin’s Lymphoma.
Ülgen, SK., Sayhan, N., Büyükbeşe, M., Geyik, G., Akdoğan, M., Şentürk, H.,
Kalaycı, C., Tözün, N.
International symposium on viral hepatitis and pespectives from the Asean region,
10-12 September 1997, Bangkok, Thailand Syllabus and Abstracts. P.85.
8. Hepatitis B and C serology by Turks living in Germany. A comparison to Turkey and
Germany in view of migration.
Akıncı, A., Şen, C., Bilgin, Y., Erkal, MZ., Geyik, G., Tözün, N., Klör, UH.
Postgraduate Course of European Association for the Study of the Liver,
26 June 1998, İstanbul, Abstracts p.122.
9. Association of HGV in Ankylosing spondilitis.
Başgül, S., Ülgen, SK., Sayhan, N., Geyik, G., Fresko, E., Demiralp, E., Direskeneli,
H., Sonsuz, A., Gül, A., Aral, A., Yazıcı, H., Tözün, N., Kalaycı, C.
Postgraduate Course of European Association for the Study of the Liver,
26 June 1998, İstanbul, Abstracts p.144.
9. Chromoendoscopy for diminutıve polyps of colon
Hamzaoğlu H,Kurtkaya Ö,Avşar E,Giral A,Enç F,Sav A,Tözün N
!st Mediterranean Congress,Samos,1998
10. Etiology of Hepatocellular carcinoma in Turkey
Uzunalimoğlu Ö,Sarıoğlu M,Çetinkaya H,Ökten A,Şahin T,çolakoğlu S,
Değertekin H,Tankurt E,Tözün N,Yurdaydın C
Hepatology 1998 ;28:769A
11. Hepa titis B and C virus serology.A comparison to Turkey and Germany in view of migration
Akıncı A,Bilgin Y,Erkal MZ,Tözün N,Bödecker R,Bretzel G,Klör U
33th Congress of European Association for the Study of the Liver,15-18 April 1998,Lisbon
Hepatology 1998 ;28:767 A
12.Therapeutic vaccination with a pre-S2 containing vaccine in chronic hepatitis B:A promising approach.
Şentürk H,Tabak F, Akdoğan M, Mert A, Erdem L, Türkoğlu S, Özbay G, Badur S,Tözün N
33th Congress of European Association for the Study of the Liver,15-18 April 1998,Lisbon
Hepatology 1998 ;28:588A
13.Thrombophilia in inflammatory bowel disease.
Hamzaoğlu H, Ülgen S,Tuğlular T, Tözün N.
World Congress of Gastroenterology,September 6-11,1998 Vienna
Digestion 1998; 59S;110
14.Hepatitis G infection in patients with Lichen Planus.
Avşar E, Ülgen S, Yücelten D, Tözün N
World Congress of Gastroenterology,September 6-11,1998 Vienna
Digestion 1998; 59S;282
15.Combination of IFN and recombinant vaccine for the treatment of chronic hepatitis B patients.
Enç F, Avşar E. Tözün N
Hepatology 30S:645A 1999
16. Comparison of thrombopoietin levels in patients with chronic liver disease
Tuğlular T,Avşar E, Ekenel M, Uras F,Tözün N
35th Congress of European Association for the Study of the Liver,29 April-3 May 2000 Rotterdam
J Hepatol 2000;32 (suppl 2):149
17. Transfusion transmitted virus in IVD abusers in Turkey
Avşar M,Türe F,Avşar E,Tamar M,Akkiprik M,Geyik G,Hamzaoğlu H,Çırakoğlu B,Tözün N
35th Congress of European Association for the Study of the Liver,29 April-3 May 2000 Rotterdam,
J Hepatol 2000;32 (suppl 2):196
18. Helicobacter pylori:The bacterium of the millenium
Tözün N
6th Mediterranean Medical Congress & 2nd Mediterranean Summer School
5-7 September 2000 Malta.Book of Abstracts.p39
19. Hepatitis B:New trends in management
Tözün N
6th Mediterranean Medical Congress & 2nd Mediterranean Summer School
5-7 September 2000 Malta.Book of Abstracts s.91
20..IBD and the liver:Eastern Mediterranean Experience
Tözün N
6th Mediterranean Medical Congress & 2nd Mediterranean Summer School
5-7 September 2000 Malta.Book of Abstracts s.98
21.Renal effects of Octreotide in cirrhosis as estimated by duplex ultrasonography and plasma-urine nitrate levels
Duman D, Tüney D,Bilsel S,Avşar E,Tözün N
6th Mediterranean Medical Congress & 2nd Mediterranean Summer School
5-7 September 2000 Malta.Book of Abstracts. S.166
22. Students perception about medical education in Marmara University School of Medicine
Kalaça S,Kan B,Çakın SA, Güney İ,Tözün N
6th Mediterranean Medical Congress & 2nd Mediterranean Summer School
5-7 September 2000 Malta.Book of Abstracts s.194
23.Incidence and risk factors for liver injury following bone marrow transplantation
ÖzenY,Ahdab H,Dane F,Özdoğan O,İmeryüz N, Ratip S,Tözün N
8th United European Gastroenterology Week,25-30 November 2000,Brussels
Gut,2000;47 S:A 172
24.Does amebiasis cause flare up of inflammatory bowel disease ?
Güney D,Över U,Hamzaoğlu H,Özdoğan O,İmeryüz N,Söyletir G,Tözün N
8th United European Gastroenterology Week,25-30 November 2000,Brussels
Gut,2000;47 S:A 224
25.Value of computed tomography in nonalcoholic steatohepatitis (NASH) .Comparison with liver biopsy
Duman DG,Tüney D,Çelikel Ç,Avşar E,Akpınar İ,Bekiroğlu N,Tözün N
36th Congress of European Association for the Study of the Liver,18-22 April 2001, Prague
J Hepatol 2001;34 (suppl 1): p.195
26. Comparison of Botulinum Toxin Injection and Lateral Internal Sphincterotomy i
n the Treatment of Chronic Anal Fissure
Giral A, Gültekin Y, Memisoglu K, Parmaksizoglu T,İmeryuz N, Ozdogan O, Kalayci C,
Tozun N, Ulusoy N
Gastrenterology 2002,122:M2045
27. Topoisomerase I and II-alpha immunoexpression in metaplastic and neoplastic
gastric mucosa
Avsar E, Celikel C, Sezgin S, Bozbas A, Duman D, Hamzaoglu H, Tozun N
Gut 2002; 51(suppl III) A 199
28.Gastrointestinal tract cancer in southeastern Europe: A multinational study with the
participation of seven countries
Yurdaydın C, Krastev Z, Bulajic M, Resuli B, Tsianos E V, Serafimoski V, Zildzic M,
Mechkov G, Tözün N,
Gut 2002; 51(suppl III) A 263
29. Effects of selective COX-2 inhibitors on gastric permeability: A controlled study with
placebo and ibuprofen
Avsar E, Ekenel M, İmeryüz N, Yüksel M, Haklar G, Tözün N
Gut 2002; 51(suppl III) A 312
30.Appendectomy and inflammatory bowel disease in the Turkish population.
Bozbaş A, Tahan V, Över Hamzaoğlu H, Tozun N. Falk symposium No 134 Trends
and controversies in
IBD-Evidence based approach or individual management. P90, 2003 Berlin-Almanya
31.Seasonal influence in exacerbations of inflammmatory bowel disease. Falk symposium
No 134 Trends and controversies in IBD-Evidence based approach or individual management.
Yılmaz M, Tahan V, Bozbaş A, Hamzaoğlu HO, Tozün N
P 53, 2003 Berlin-Almanya
32.Role of transforming growth factor beta-1 in course of chronic hepatitis C infection.
Bozbas A, Eren F, Tahan V, Duman D, Tiftikci A, Tozun N
CTC & EASGLD- Inauguration Conference 2004; abstract 158
33The prevalence of hepatic granulomas in chronic hepatitis C
Ozaras R, Tahan V,Mert A Tabak F,Avsar E,Ozbay G,Celikel C,Tözün N
Senturk H
13th European Congress of Clinical Microbiology and Infectious Diseases.
10-13 May, 2003, Glasgow, UK
Clinical Microbiology and Infection 2003,9: suppl 1,279
34.Assessment of nutrition in liver cirrhosis
Tasan G, Tozun N Tahan V, Enc F, Giral A ,Imeryuz N, Avsar E, Kalayci C
38Th Meeting of the European Assocation for the Study of the Liver,Geneva
July 2nd -6 th, 2003 , J Hepatol 2003, suppl 2: 201
35.Sexual Transmission of HCV between spouses
Tahan V, Karaca Ç,Yıldırım B,Bozbas A, Demir K,Avşar E, Mert A,Tabak F,
Beşışık F,Kaymakoglu S,Cakaloglu Y, Kalayi C,Okten A, Tozun N
38Th Meeting of the European Assocation for the Study of the Liver,Geneva
July 2nd -6 th, 2003 , J Hepatol 2003, suppl 2: 176
36.Rosiglitazone attenuates Liver Inflammation In A Rat Model Of Non-Alcoholic Steatohepatitis
Tahan V, Eren F, Yavuz D, Emekli E, Yuksel M , Goren Z, Celikel C, Haklar G,
Avsar E, Tozun N
38Th Meeting of the European Assocation for the Study of the Liver,Geneva July
2nd -6 th, 2003 , J Hepatol 2003, suppl 2:202
37.Clinical and demographic characteristics of patients with non alcoholic steatohepatitis.
A multicenter study
Sarıoğlu MK,Akarca S, Sonsuz A, Duman D,Tankut E, Degertekin
H,Suleymanlar I, Tozun N,Yurdaydin C,Uzunalimoglu O
38Th Meeting of the European Assocation for the Study of the Liver,Geneva
July 2nd -6 th, 2003 , J Hepatol 2003, suppl 2:200
38.Adrenomedullin: A Trigger or Bystander in Cirrhotic and Non-Cirrhotic Portal Hypertension?
Tahan V, Karaca C, Uslu E, Eren F., Aydin S, Uzun H Hamzaoglu HO,. Besisik F,
Avsar E., Kalayci C, Okten A, Tozun N.
6th African Association for Study of Liver Disease, March 3-6, 2003, p 32, Cairo, Egypt.
39.Common CARD15/NOD2 mutations in Turkish population:
no association with Behçet’s disease.
Uyar FA, Over Hamzaoğlu H, Ture F, Tozun N, Saruhan –Direskeneli G, Gul A
15th European Immunology Congress 2003 Rhodes - Greece
40. Fatty liver and non alcoholic steatohepatitis:Knowledge is the past hope is the future
Tozun N
The 8th International Congress of the Egyptian Society of Hepatology,
Gastroenterology and Infectious Diseases.
12-16 October 2003, Cairo. Abstract Book p.3-4
41. Anti-HCV Seroprevalence in Chronic HCV Patient’s Children in Turkey
Tahan V., Yildirim B., Ture F.,. Giral A,. Ozdogan O,. Imeryuz N,. Avsar E,
Mert A, Senturk H, Kalayci C, Tozun N.
XII Falk Liver Week 2003 October 17-19, Freiburg; Germany.
42. Awareness Of Transmission Route Of HCV among Health Care Professionals
HCV-Infected Patients And Their Relatives
Tiftikci A, Zeytinoglu D, Sagnic S, Taneroglu S, Arer I, Bekiroglu N, Tahan V, Tozun N.
7th Mediterranean Medical Congress & 3dr Mediterranean Medical School
7-9 November 2003,Vilamoura,Portugal. Abstract Book p.32
43.Leading Cause Of Non-Variceal Upper Gastrointestinal Bleeding Is Peptic Ulcer
Tiftikci A, Zeytinoglu D, Sagnic S, Taneroglu S, Arer I, Bekiroglu N, Tahan V, Tozun N.
7th Mediterranean Medical Congress & 3dr Mediterranean Medical School.
7-9 November 2003,Vilamoura,Portugal .Abstract Book p.9
44. Fatty Liver and Non Alcoholic Steatohepatitiis
Tozun N
7th Mediterranean Medical Congress & 3dr Mediterranean Medical School.7-9
November 2003,Vilamoura,Portugal .Abstract Book p.52-54
45. Is serum hyaluronic acid a surrogate marker predicting liver fibrosis in NAFLD
Duman D,Tahan V,Alpay N,Taninmiş H,Haklar G,Celikel C,Avsar E,Kalayci C, Tozun N
Advances in the Management of GI Cancer.13th World Congress of the
International Associatons of Surgeons and Gastroenterologists, 3-6 December 2003-12-14
Estoril,Portugal Abstracts Hepatogastroenterology 2003, 50 suppl p126
46.Bouveret’s syndrome complicated by a distal gallstone ileus: case report
Gençosmanoğlu R, Inceoğlu R, Baysal Ç, Akansel S, Tozun N
Advances in the Management of GI Cancer.13th World Congress of the
International Associatons of Surgeons and Gastroenterologists, 3-6 December 2003-12-14
Estoril,Portugal Abstracts Hepatogastroenterology 2003, 50 suppl.p.154
47.The Buried Bumper Syndrome:Migration of the internal bumper of percutaneous
endoscopic gastrostomy tube into the abdominal wall;case report
Gencosmanoglu R, Koc D, Tozun N.
Advances in the Management of GI Cancer.13th World Congress of the
International Associatons of Surgeons and Gastroenterologists, 3-6 December 2003-12-14
Estoril,Portugal Abstracts Hepatogastroenterology 2003, 50 suppl OP 21
48. Pentoxyfillin (PO)inhibits TNF-alpha production by peripheral blood mononuclear cells
.n patients with Non Alcoholic Steatohepaitis (NASH)
Duman DG,Ozdemir FT,Demiralp E, Celikel C,Kalayci O,Tozun N, Kalayci C
39.th Annual Meeting of the Eurppean Association for the Study of the Liver
April 14-18 2004, Berlin.J Hepatol 2004; 40 S1:171
49.Role of transforming growth factor beta-1 in course of chronic hepatitis C infection.
Bozbas A, Eren F, Tahan V, Duman D, Tiftikci A, Tozun N
CTC & EASGLD- Inauguration Conference 2004; Abstract 158
50. The effect of rosıglıtazone on methıonıne and cholıne defıcıent dıet model of
non- alcoholıc steatohepatıtıs ın rats
Tahan V , Avşar E, Eren F, Yavuz D, Emekli E, Yüksel M, Gören Z, Imeryuz N,
Çelikel Ç, Haklar G, Tozun N. 39.th Annual Meeting of the European Association
for the Study of the Liver
April 14-18 2004, Berlin .J Hepatol 2004; 40 S1:172
51.Barghi I. Unal O. Turgut D. Nazlı A. Saglam B. Tiftikci A. İmeryüz N. Ovunc O. Abut E. Tozun N.
Alternative medicine in gastroenterologic patients: their interest and knowledge.
J. Of Gastro& Hepato Vol. 19 (suppl) APASL abstract 304
52. Awareness of health care staff, HCV infected patients and household contacts of
HCV transmission routes:
Tiftikci A, Zeytinoglu D, Sagnic S, Taneroglu S, Arer I, Bekiroglu N , Tahan V, Tozun N.
40th Annual Meeting of the European Association for the Study of the
Liver. April 13-17 , 2005, Paris .J Hepatol 2005; 42 S2:223
53.Rosiglitazone shows an anti-inflammatory effect by decreasıng interleukin- 6
in a rat model of non-alcoholic steatohepatitis
Tahan V,Imeryuz N,Uzun H,Eren F,Gogas D,Barhghi ,Celikel C, Avsar E,Tozun N
40th Annual Meeting of the European Association for the Study of the Liver.
April 13-17 , 2005, Paris .J Hepatol 2005; 42 S2:254
54. Role of Ursodeoxycholic Acid in the prevention of methotrexate induced liver toxicity
40th Annual Meeting of the European Association for the Study of the Liver.
April 13-17 , 2005, Paris .J Hepatol 2005; 42 S2:255
55. .Rosiglitazone has an antiinflammatory effect by decreasing inflammatory cytokines in a rat model of NASH
Tahan V,İmeryüz N,Eren F,Uzun H,Gogas D,Celikel C,Avsar E,Tozun N
Poster 0794,World Congress of Gastroenterology Montreal Canada ,
September 8-11 2005 Presidential poster
4.Excerpta Medica Ya Da Diğer Ulusal/Uluslararsı Endekslerde Taranan Dergilerdeki Yayınlar
1. Mirizzi syndrome (Report of three cases)
Ökten, A., Tözün, N., Yalçın, S., Arıoğul, O., Yeğinsu, O., Ulagay, I.
Med Bull İstanbul 17: 137-143, 1984.
2. Growth retardation in Crohn’s disease
Tözün, N., Erol, N., Yıldır, C., Emre, A., Yalçın, S., Sezer, R., Yeğinsu, O.
Med Bull İstanbul 17: 144-154, 1984.
3.. Diagnostic accuracy of ERCP: Comparison with ultrasonography and computed tomography.
Ulusoy, N. B., Tözün, N., Kalaycı, C., Gürmen, N., Minareci, Ö.,
Dolunay, F., Calay, M., Bayram, M., Kuşculu, N., Yakın, G.
Med Bull Istanbul 21: 179-188, 1988.
4. Plasma atrial natriuretic factor in chronic liver disease.
Tözün, N., Ulusoy, N. B., Taga, Y., Kalaycı, C., Ökten, A., Berkman, K.
Marmara Med J 2: 82-86, 1989.
5. Colorectal polyps with early invasive cancer. Endoscopic removal or resection ?
Tankurt, E., Tözün, N., Kalaycı, C., Ulusoy, N. B.,
Marmara Med J 3: 156-161, 1990.
6. Hyperplastic polyps of the large bowel: A possible marker role for adenomas.
Tankurt, E., Tözün, N., Direskeneli, H., Kalaycı, C., Ulusoy, N. B.
Turk J Gastroenterology 2: 99-102, 1991.
7. Prevelance of helicobacter pylori infection among patients with end-stage chronic renal
failure on hemodialysis programme.
Tankurt, E., Tözün, N., Kalaycı, C. Gültekin, OSG., Ulusoy NB.
Turk J Gastroenterohepatol 3: 206-208, 1992.
8. Cholelithiasis and acute cholecystitis in patients with chronic liver disease.
Tözün, N., Alpdoğan, Ö., Avşar, E.,Tankurt, E., Kalayı, C., İnceoğlu, R.,
Yalın, R.
Marmara Med J 8: 88-91, 1995.
9. A case of glycogen storage disease type III.
Kırış, S., Özdoğan, O., Avşar, E., Kalaycı, C., Tözün, N., Ulusoy, NB.
Marmara Med J 9: 28-31, 1996.
10. Prevalance of helicobacter pylori in endoscopists.
Tözün, N., Durademir, A., Avşar, E., Özdoğan, O., Kalaycı, C., Tankurt, E., Ulusoy, NB., Bekiroğlu, N.
Marmara Med J 10: 33-35, 1997
11. Five cases of carcinoma of the papilla of Vater with double primary malignancies
Kalaycı C, Özdoğan O, Küllü S, Tözün N, Ulusoy N.
Marmara Med J .1998;11:43-47
12. Hepatitis G virus: Structure, epidemiology and clinical significance.
Avşar, E., Tözün, N
Marmara Med J 1998; 11:113-16
13. Student’s perception about medical education at Marmara University School of Medicine
Kalaça S,Kan B,Çakın A,Güney İ,Tözün N
Marmara Med J 2000:13:131-137
14. Percutaneous endoscopic gastrostomy:results of 50 cases
Gençosmanoğlu R,Şad O,Avşar E,Hamzaoğlu H,Özdoğan O,Kalaycı C,Tözün N
Marmara Med J 2000;13:212-219
15. The Buried Bumper Syndrome: A Rare Complication of Percutaneous Endoscopic Gastrostomy (Case Report)
Gençosmanoğlu R, Şad O, Hamzaoğlu HÖ, Avşar E, Tözün N.
Clinical & Experimental Surgery, 8(3), 149-152 (2000).
16.The effect of sedation with intravenous midazolam in 100 patients undergoing upper gastrointestinal endoscopy
Koç D,Gençosmanoğlu R,Şad O,Tözün N
Marmara Med J 2001;14:96-101
5. Uluslararası kitaplarda basılı yayınlar (Tam makale)
1.Role of protein C in Thrombus formation in cases of presinusoidal and postsinusoidal
portal hypertension.
Tözün N., Ökten A., Yardımcı T.
İn Thrombosis and Hemorrhagic Disease. O.N.Ulutin and H. Vinazzer (eds).
Proceedings of IV th International Meeting of
Danubian League Against Thrombosis and hemorrhagic Diseases,
Sept. 25-28 1985, p. 404-408.
2.Medical management of upper GI bleeding.
Tözün N.
Proceedings of the symposium on recent advances in Cardiovascular Surgery,
Pulmonary Disease, Gastroenterology and Urology.
July 1-2, 1993, İstanbul, p. 111-117.
3.Extrahepatic manifestations of viral hepatitis.
Tözün N.
Syllabus of Postgraduate Course of European Association for the Study of the
Liver, 26 June 1998, İstanbul, p.14-24.
4.Medical therapy of inflammatory bowel disease
Tözün N
Mediterranean Medical Society
Syllabus of 1 st Mediterranean Summer School 1998
Edit D.Tsantoulas,Samos Greece
p.122-129,1998
6. Uluslararası kitaplarda Editör/editor yardımcılığı
VI International Symposium on Inflammatorty Bowel Diseases
D Rachmilewitz,R Modigliani,DB Sachar, DK Podolsky and N.Tözün Eds
Kluver Academic Publishers, 2002 |
|
